Matthias Rath Selected Research

Drug Therapy (Chemotherapy)

10/2006	In vivo and in vitro antitumor effect of a unique nutrient mixture on lung cancer cell line A-549.
3/2005	In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry.
2/2005	Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
1/2005	Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Rath Research Topics

Disease

39	Neoplasms (Cancer) 12/2020 - 01/2004
23	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2005
9	Melanoma (Melanoma, Malignant) 01/2019 - 01/2006
5	Infections 11/2023 - 01/2008
4	Ovarian Neoplasms (Ovarian Cancer) 03/2017 - 04/2006
4	Breast Neoplasms (Breast Cancer) 09/2016 - 01/2005
4	Osteosarcoma (Osteogenic Sarcoma) 10/2013 - 02/2005
4	Lung Neoplasms (Lung Cancer) 06/2013 - 10/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2015
3	Fibrosarcoma 09/2016 - 01/2006
3	Atherosclerosis 01/2015 - 05/2010
3	Body Weight (Weight, Body) 04/2014 - 01/2007
3	Malignant Mesothelioma 06/2013 - 03/2006
2	COVID-19 06/2022 - 02/2022
2	Ascorbic Acid Deficiency (Vitamin C Deficiency) 01/2021 - 01/2021
2	Lyme Disease (Disease, Lyme) 01/2020 - 06/2016
2	Brain Neoplasms (Brain Tumor) 03/2017 - 08/2014
2	Glioblastoma (Glioblastoma Multiforme) 03/2017 - 08/2014
2	Inflammation (Inflammations) 09/2016 - 04/2014
2	Carcinogenesis 09/2016 - 07/2009
2	Carcinoma (Carcinomatosis) 07/2015 - 10/2006
2	Glioma (Gliomas) 08/2014 - 01/2007
2	Sarcoma (Soft Tissue Sarcoma) 10/2013 - 07/2013
2	Sepsis (Septicemia) 01/2013 - 11/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2006 - 01/2006
2	Prostatic Neoplasms (Prostate Cancer) 01/2005 - 01/2004
1	Thrombocytopenia (Thrombopenia) 12/2023
1	Coronavirus Infections 07/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Central Nervous System Cavernous Hemangioma 01/2021

Drug/Important Bio-Agent (IBA)

30	Matrix Metalloproteinases (MMPs)IBA 06/2017 - 01/2004
28	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021 - 01/2004
24	TeaIBA 01/2019 - 01/2005
23	Lysine (L-Lysine)FDA Link 01/2019 - 01/2004
23	Proline (L-Proline)FDA Link 01/2019 - 01/2004
18	Arginine (L-Arginine)FDA Link 07/2009 - 01/2004
15	matrigelIBA 09/2016 - 01/2004
9	GelatinasesIBA 08/2014 - 01/2005
8	Antineoplastic Agents (Antineoplastics)IBA 04/2014 - 01/2004
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 01/2005
7	MicronutrientsIBA 07/2023 - 10/2006
7	Peptide Hydrolases (Proteases)FDA Link 07/2015 - 12/2009
6	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2005
5	Fibronectins (Fibronectin)IBA 09/2015 - 01/2005
5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2014 - 09/2012
5	FibrinIBA 08/2014 - 09/2012
5	Therapeutic UsesIBA 03/2012 - 01/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 01/2007
4	QuercetinIBA 01/2019 - 03/2010
4	CytokinesIBA 06/2017 - 12/2009
4	Methylnitronitrosoguanidine (MNNG)IBA 10/2013 - 02/2005
4	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 04/2006 - 01/2004
3	VaccinesIBA 07/2023 - 05/2011
3	Lipoprotein(a)IBA 01/2021 - 01/2015
3	CopperIBA 03/2012 - 12/2005
3	SeleniumIBA 03/2012 - 12/2005
3	MucinsIBA 01/2006 - 01/2005
2	LipidsIBA 01/2021 - 01/2015
2	CollagenIBA 01/2021 - 09/2015
2	Matrix Metalloproteinase InhibitorsIBA 06/2017 - 03/2017
2	MitogensIBA 03/2017 - 12/2009
2	Amino Acids FDA Link 09/2016 - 11/2012
2	Capsules (Microcapsules)IBA 09/2015 - 01/2013
2	Tissue Inhibitor of Metalloproteinase-2IBA 08/2014 - 05/2013
2	Plasminogen Activators (Plasminogen Activator)IBA 08/2014 - 09/2012
2	Dihydrotachysterol (AT 10)IBA 01/2013 - 01/2007
2	phorbolIBA 03/2012 - 10/2006
2	EnzymesIBA 05/2011 - 01/2006
2	Angiotensin IIIBA 07/2010 - 05/2010
2	Apolipoproteins E (ApoE)IBA 07/2010 - 05/2010
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 03/2010 - 01/2005
2	ManganeseIBA 07/2009 - 12/2005
2	Cysteine (L-Cysteine)FDA Link 07/2009 - 12/2005
2	Bovine Serum AlbuminIBA 01/2007 - 04/2006
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2006 - 02/2005
2	Penicillins (Penicillin)FDA Link 04/2006 - 10/2005
2	Streptomycin (Streptomycin Sulfate)FDA Link 04/2006 - 10/2005
1	Nonmuscle Myosin Type IIAIBA 12/2023
1	Complement System Proteins (Complement)IBA 07/2023
1	PhytochemicalsIBA 07/2023
1	Gallic AcidIBA 09/2022
1	von Willebrand FactorIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	Interleukin-2 (IL2)IBA 12/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 12/2020
1	baicaleinIBA 01/2020
1	monolaurinIBA 01/2020
1	Rosmarinic AcidIBA 01/2020
1	AcidsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	IodineIBA 01/2020
1	LuteolinIBA 01/2020
1	Hormones (Hormone)IBA 01/2019

Therapy/Procedure

7	Therapeutics 01/2019 - 01/2007
4	Drug Therapy (Chemotherapy) 10/2006 - 01/2005
2	Injections 04/2014 - 11/2006
2	Intraperitoneal Injections 03/2010 - 07/2009
1	Immunotherapy 12/2020